सत्यापित हो रहा है..
स्वचालित रूप से अनुवादित। खुराक और चेतावनियाँ: मूल अंग्रेज़ी में देखें। अंग्रेज़ी में पढ़ें

Afrabron Tablets

NAFDAC Reg. No. A11-100684 · दवा

NAFDAC के साथ रजिस्टर किया गया। रजिस्ट्रेशन ऐक्टिव हैAs of 31 October 2026 · synced automatically from official sources.
उत्पाद
Afrabron Tablets
NAFDAC नंबर
A11-100684
सक्रिय घटक
Iron (Iron polymaltose); Folic acid
प्रबलता
1 mg; 100 mg
Form
Tablet
Pack size
3 x 10's (in blisters)
Manufacturer
Not listed
Applicant (holder)
Afrab-Chem Limited
Approved
27 Mar 2024
Status
Active View on NAFDAC ↗
Registration valid to
26 Mar 2029
WHO alerts
None found
Community reports
None
Times checked
0

About the medicine: Iron: uses, dosage and brands worldwide

What we found

  • Afrabron Tablets is on the NAFDAC register with an active registration (A11-100684). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Afrabron Tablets

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Serious warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
यह किसके लिए है

IROSPAN 24/6 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs.

How to take it and how often
  • Usual adult dosage is 1 tablet daily or as directed by a physician
  • The IROSPAN® carton contains a 30 day course of iron therapy that consists of 24 light blue tablets and 6 white tablets
  • Take 1 light blue tablet daily for 24 days, followed by 1 white tablet daily for 6 days
  • After the 30 tablets have been taken, a new course may be started if prescribed
Talk to a doctor first if
  • Ingestion of more than 3 grams of omega-fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR
  • Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis
  • Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient
Warnings

P recautions: Folic acid in doses above 0.1mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. This product contains formate, which if consumed above the recommended level, could cause visual impairment and other health effects. Do not take more than the recommended amount. If you are pregnant, nursing, or taking any medications consult your doctor before use. Discontinue use and consult your doctor if any adverse reactions occur. Not intended for use by persons under the age of 18.

Possible side effects

A dverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-05-13.

Label for iron (iron polymaltose) and folic acid, the active ingredient registered with NAFDAC.

Check your pack of Afrabron Tablets

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Afrabron Tablets

What is in Afrabron Tablets?

Afrabron Tablets contains Iron (Iron polymaltose); Folic acid (1 mg; 100 mg), as tablet, according to its NAFDAC registration record.

Is Afrabron Tablets registered with NAFDAC?

Yes. Afrabron Tablets is listed on the NAFDAC register under registration number A11-100684, and its registration is active as of 31 October 2026.

Has Afrabron Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Afrabron Tablets in our automatically synced alert list.

How can I check that my pack of Afrabron Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A11-100684, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Afrabron Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Usual adult dosage is 1 tablet daily or as directed by a physician. The IROSPAN® carton contains a 30 day course of iron therapy that consists of 24 light blue tablets and 6 white tablets. Take 1 light blue tablet daily for 24 days, followed by 1 white tablet daily for 6 days. After the 30 tablets have been taken, a new course may be started if prescribed.…

What is Afrabron Tablets used for?

IROSPAN 24/6 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These include: hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs. (Summarised from the official U.S. FDA label for iron (iron polymaltose) and folic acid. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Afrabron Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.